Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 19/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4217423 | 0.94 | KISS1R (0.53) | KISS1RMEN1KMT2A | |
| SCHEMBL5017428 | 0.92 | KISS1R (0.52) | KISS1R | |
| SCHEMBL4205801 | 0.91 | KISS1R (0.54) | KISS1RMEN1KMT2A | |
| SCHEMBL4217888 | 0.89 | KISS1R (0.61) | KISS1R | |
| SCHEMBL4205536 | 0.89 | KISS1R (0.59) | KISS1RMEN1KMT2A | |
| SCHEMBL4210388 | 0.88 | KISS1R (0.73) | KISS1R | |
| SCHEMBL4217598 | 0.87 | KISS1R (0.47) | KISS1R | |
| SCHEMBL5065155 | 0.86 | KISS1R (0.53) | KISS1RMEN1KMT2A | |
| SCHEMBL4204198 | 0.85 | KISS1R (0.64) | KISS1R | |
| SCHEMBL5136062 | 0.85 | KISS1R (0.50) | KISS1RMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090156646-A1 | PYRIDYLPHENOL COMPOUND AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-06-18 | — | — | US | disclosed |
| EP-1921066-A1 | PYRIDYLPHENOL COMPOUND AND USE THEREOF | Takeda Pharmaceutical Company Limited (JP) | 2008-05-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090156646-A1 | PYRIDYLPHENOL COMPOUND AND USE THEREOF | GNRHR, PGR, MC1R | KISS1R 16/4885MEN1 64/4885POLB 2582/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.